ERBB2 and neoplasm: CI-1033 was evaluated for its ability to inhibit tumor formation in esophageal squamous cell carcinoma (TT, TE2, TE6, TE10 cell lines) in vitro and in vivo with EGFR and HER2 overexpression in all four cell lines [58].